ScoreWhy is Gufic BioSciences Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 14.74% and Operating profit at 13.39% over the last 5 years
2
The company has declared positive results in Mar'2026 after 5 consecutive negative quarters
- PBT LESS OI(Q) At Rs 30.12 cr has Grown at 88.6% (vs previous 4Q average)
- DEBTORS TURNOVER RATIO(HY) Highest at 3.17 times
- OPERATING PROFIT TO INTEREST(Q) Highest at 5.00 times
3
With ROCE of 12.1, it has a Very Expensive valuation with a 4.4 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 11.09%, its profits have fallen by -9.7%
4
Majority shareholders : Promoters
5
Consistent Returns over the last 3 years
- Along with generating 11.09% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Gufic BioScience should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Gufic BioScience for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Gufic BioScience
11.27%
0.33
34.24%
Sensex
-1.97%
-0.15
13.56%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.74%
EBIT Growth (5y)
13.39%
EBIT to Interest (avg)
4.10
Debt to EBITDA (avg)
2.14
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
1.33
Tax Ratio
25.80%
Dividend Payout Ratio
1.43%
Pledged Shares
0
Institutional Holding
4.14%
ROCE (avg)
20.50%
ROE (avg)
10.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
63
Industry P/E
37
Price to Book Value
6.11
EV to EBIT
36.45
EV to EBITDA
29.03
EV to Capital Employed
4.42
EV to Sales
4.65
PEG Ratio
NA
Dividend Yield
0.02%
ROCE (Latest)
12.13%
ROE (Latest)
9.66%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
PBT LESS OI(Q)
At Rs 30.12 cr has Grown at 88.6% (vs previous 4Q average
DEBTORS TURNOVER RATIO(HY)
Highest at 3.17 times
OPERATING PROFIT TO INTEREST(Q)
Highest at 5.00 times
NET SALES(Q)
Highest at Rs 251.82 cr
PBDIT(Q)
Highest at Rs 47.21 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 18.75%
PAT(Q)
Highest at Rs 21.90 cr.
EPS(Q)
Highest at Rs 2.18
-3What is not working for the Company
INTEREST(9M)
At Rs 27.38 cr has Grown at 21.47%
Loading Valuation Snapshot...
Here's what is working for Gufic BioScience
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 30.12 cr has Grown at 88.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 15.97 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 5.00 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit After Tax (PAT) - Quarterly
At Rs 21.90 cr has Grown at 75.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 12.51 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Highest at 3.17 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Net Sales - Quarterly
Highest at Rs 251.82 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 47.21 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 18.75%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 30.12 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 21.90 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.18
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Gufic BioScience
Interest - Nine Monthly
At Rs 27.38 cr has Grown at 21.47%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
